UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$425M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$375M |
| 3 |
CRH
CRH
|
+$264M |
| 4 |
Advanced Micro Devices
AMD
|
+$216M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$205M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$523M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$455M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$382M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
UnitedHealth
UNH
|
+$320M |
Sector Composition
| 1 | Technology | 16.51% |
| 2 | Financials | 8.9% |
| 3 | Healthcare | 8.35% |
| 4 | Consumer Discretionary | 6.66% |
| 5 | Industrials | 5.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Vera Therapeutics
VERA
$1.68B
| $602K | ﹤0.01% |
43,935
+23,202
| +112% | +$318K |
|
3477
Ramaco Resources Class A
METC
$2.04B
| $602K | ﹤0.01% |
56,631
-69,762
| -55% | -$742K |
|
3478
Invesco Bond Fund
VBF
$181M
| $601K | ﹤0.01% |
41,539
+8,734
| +27% | +$126K |
|
|
TSI
3479
TCW Strategic Income Fund
TSI
$239M
| $601K | ﹤0.01% |
131,155
-15,519
| -11% | -$71.1K |
|
3480
MYR Group
MYRG
$2.86B
| $599K | ﹤0.01% |
4,445
-8,541
| -66% | -$1.15M |
|
|
LGF.B
3481
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $598K | ﹤0.01% |
76,017
-27,416
| -27% | -$216K |
|
3482
C4 Therapeutics
CCCC
$236M
| $598K | ﹤0.01% |
321,609
+51,807
| +19% | +$96.4K |
|
3483
Belpointe PREP
OZ
$245M
| $596K | ﹤0.01% |
6,950
+2,382
| +52% | +$204K |
|
3484
Kennametal
KMT
$1.62B
| $593K | ﹤0.01% |
23,838
-18,248
| -43% | -$454K |
|
3485
Vanguard US Value Factor ETF
VFVA
$710M
| $592K | ﹤0.01% |
5,917
-20,765
| -78% | -$2.08M |
|
3486
Paylocity
PCTY
$9.1B
| $592K | ﹤0.01% |
3,258
-8,318
| -72% | -$1.51M |
|
|
MNP
3487
DELISTED
Western Asset Municipal Partners Fund, Inc.
MNP
| $592K | ﹤0.01% |
55,948
+156
| +0.3% | +$1.65K |
|
3488
LG Display
LPL
$4.84B
| $591K | ﹤0.01% |
121,087
+102,963
| +568% | +$502K |
|
3489
CareTrust REIT
CTRE
$7.73B
| $590K | ﹤0.01% |
28,765
-133,938
| -82% | -$2.75M |
|
|
RCS
3490
PIMCO Strategic Income Fund
RCS
$350M
| $589K | ﹤0.01% |
110,965
-492
| -0.4% | -$2.61K |
|
3491
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
$12.4B
| $588K | ﹤0.01% |
22,044
-138
| -0.6% | -$3.68K |
|
3492
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.42B
| $588K | ﹤0.01% |
11,205
-1,851
| -14% | -$97.1K |
|
3493
Sweetgreen
SG
$1.02B
| $588K | ﹤0.01% |
50,026
+19,945
| +66% | +$234K |
|
3494
Grupo Aeroportuario del Sureste
ASR
$10.1B
| $586K | ﹤0.01% |
2,385
+1,750
| +276% | +$430K |
|
3495
Appian
APPN
$2.45B
| $585K | ﹤0.01% |
12,833
-10,596
| -45% | -$483K |
|
|
PNT
3496
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $585K | ﹤0.01% |
87,639
+24,463
| +39% | +$163K |
|
3497
American Homes 4 Rent
AMH
$12.4B
| $583K | ﹤0.01% |
17,316
-152,391
| -90% | -$5.13M |
|
3498
Celldex Therapeutics
CLDX
$1.72B
| $583K | ﹤0.01% |
21,195
+20,418
| +2,628% | +$562K |
|
3499
Douglas Dynamics
PLOW
$763M
| $583K | ﹤0.01% |
19,314
-3,665
| -16% | -$111K |
|
3500
Triumph Financial, Inc.
TFIN
$1.41B
| $582K | ﹤0.01% |
8,988
-2,022
| -18% | -$131K |
|